Mirati Financial Statements From 2010 to 2024
MRTXDelisted Stock | USD 31.32 0.15 0.48% |
Check Mirati Ther financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mirati Ther's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mirati financial statements analysis is a perfect complement when working with Mirati Ther Valuation or Volatility modules.
Mirati |
Mirati Ther Company Return On Asset Analysis
Mirati Ther's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mirati Ther Return On Asset | -0.39 |
Most of Mirati Ther's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mirati Ther is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Mirati Ther has a Return On Asset of -0.393. This is 95.51% lower than that of the Biotechnology sector and 98.33% lower than that of the Health Care industry. The return on asset for all United States stocks is 180.71% higher than that of the company.
Mirati Ther Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mirati Ther's current stock value. Our valuation model uses many indicators to compare Mirati Ther value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mirati Ther competition to find correlations between indicators driving Mirati Ther's intrinsic value. More Info.Mirati Ther is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mirati Ther's earnings, one of the primary drivers of an investment's value.About Mirati Ther Financial Statements
Mirati Ther investors use historical fundamental indicators, such as Mirati Ther's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mirati Ther. Please read more on our technical analysis and fundamental analysis pages.
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California. Mirati Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
CEOs Directory Screen CEOs from public companies around the world |